Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Profit After Tax (2022 - 2025)

Historic Profit After Tax for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$6.5 million.

  • Envoy Medical's Profit After Tax fell 875.84% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.8 million, marking a year-over-year decrease of 339.79%. This contributed to the annual value of -$20.8 million for FY2024, which is 3050.26% up from last year.
  • As of Q3 2025, Envoy Medical's Profit After Tax stood at -$6.5 million, which was down 875.84% from -$5.7 million recorded in Q2 2025.
  • Envoy Medical's Profit After Tax's 5-year high stood at $12.5 million during Q1 2022, with a 5-year trough of -$13.3 million in Q1 2023.
  • Over the past 4 years, Envoy Medical's median Profit After Tax value was -$5.0 million (recorded in 2025), while the average stood at -$4.3 million.
  • Over the last 5 years, Envoy Medical's Profit After Tax had its largest YoY gain of 21672.89% in 2023, and its largest YoY loss of 52857.34% in 2023.
  • Over the past 4 years, Envoy Medical's Profit After Tax (Quarter) stood at -$11.5 million in 2022, then skyrocketed by 57.35% to -$4.9 million in 2023, then grew by 5.66% to -$4.6 million in 2024, then tumbled by 40.36% to -$6.5 million in 2025.
  • Its Profit After Tax was -$6.5 million in Q3 2025, compared to -$5.7 million in Q2 2025 and -$5.0 million in Q1 2025.